Publications Archive - Page 4 of 10 - KalVista Pharmaceuticals

Showing 31-40 out of 98

Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks

Tachdjian R, Savic S, Fridman M, Frade JP, Fasehun M, Audhya PK

Allergy and Asthma Proceedings

Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment with Them

Geng B, van Kooten S, Heckmann M, Danese S, Goga L, Radojicic C

ACAAI 2023

Treatment of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) –A Real-World ACARE Survey

Marcus Maurer M, Markus Magerl M, Marc A, Riedl MA, Sherry Danese S, Julie Ulloa J, Vibha Desai V, Paul K, Audhya PK

ACAAI 2023

Treatment Patterns Among Individuals with Hereditary Angioedema in the United States

Tachdjian R, Chang R, DerSarkissian M, Cribbs KA, Lahue BJ, Czado S, Desai V

ACAAI 2023

Diagnosing Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) –A Real World ACARE Survey

Riedl MA, Magerl M, Maurer M, Danese S, Ulloa J, Desai V, Audhya PK

ACAAI 2023

Refining Prevalence Estimates of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH)

Magerl M, Riedl MA, Maurer M, Danese S, Ulloa J, Desai V, Audhya PK

ACAAI 2023

Anxiety Associated with On-Demand Treatment of HAE Attacks May Result in Suboptimal Attack Management

Manning M, van Kooten S, Heckmann M, Danese S, Goga L, Ogbogu PU

ACAAI 2023

Hereditary Angioedema Attacks in Patients Receiving Long-Term Prophylaxis: A Systematic Review

Longhurst HJ, Bouille L, Cancian M, Grivcheva-Panovska V, Koleilat M, Magerl M, Savic S, Stobieck Mi, Tachdjian R, Yea CM, Audhya PK

APAAACI 2023

KONFIDENT Phase 3 Trial Global Expansion: Sebetralstat Pharmacokinetics and Pharmacodynamics in Japanese and Chinese Adults

Honda D, Iverson M, Hansen E, Hampton SL, Jhee S, Yoon E, Audhya PK, Smith MD, Yea CM, Hide M

APAAACI 2023

Investigating On-Demand Use of Oral Sebetralstat in Adults and Adolescents With Hereditary Angioedema: Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 KONFIDENT Trial and Open-Label Extension Designs

Hide M, Audhya PK, Smith MD, Yea CM

JSA 2023

About

Science

Pipeline

Careers

Contact